Virology Unit, Institut Pasteur de Madagascar, 101, Antananarivo, Madagascar.
Institut Pasteur, 75015, Paris, France.
BMC Infect Dis. 2022 Nov 8;22(1):821. doi: 10.1186/s12879-022-07826-0.
Poliomyelitis outbreaks due to pathogenic vaccine-derived polioviruses (VDPVs) are threatening and complicating the global polio eradication initiative. Most of these VDPVs are genetic recombinants with non-polio enteroviruses (NPEVs) of species C. Little is known about factors favoring this genetic macroevolution process. Since 2001, Madagascar has experienced several outbreaks of poliomyelitis due to VDPVs, and most of VDPVs were isolated in the south of the island. The current study explored some of the viral factors that can promote and explain the emergence of recombinant VDPVs in Madagascar.
Between May to August 2011, we collected stools from healthy children living in two southern and two northern regions of Madagascar. Virus isolation was done in RD, HEp-2c, and L20B cell lines, and enteroviruses were detected using a wide-spectrum 5'-untranslated region RT-PCR assay. NPEVs were then sequenced for the VP1 gene used for viral genotyping.
Overall, we collected 1309 stools, of which 351 NPEVs (26.8%) were identified. Sequencing revealed 33 types of viruses belonging to three different species: Enterovirus A (8.5%), Enterovirus B (EV-B, 40.2%), and Enterovirus C (EV-C, 51.3%). EV-C species included coxsackievirus A13, A17, and A20 previously described as putative recombination partners for poliovirus vaccine strains. Interestingly, the isolation rate was higher among stools originating from the South (30.3% vs. 23.6%, p-value = 0.009). EV-C were predominant in southern sites (65.7%) while EV-B predominated in northern sites (54.9%). The factors that explain the relative abundance of EV-C in the South are still unknown.
Whatever its causes, the relative abundance of EV-C in the South of Madagascar may have promoted the infections of children by EV-C, including the PV vaccine strains, and have favored the recombination events between PVs and NPEVs in co-infected children, thus leading to the recurrent emergence of recombinant VDPVs in this region of Madagascar.
由致病性疫苗衍生脊髓灰质炎病毒(VDPV)引起的脊髓灰质炎疫情对全球消灭脊髓灰质炎倡议构成威胁并使之复杂化。这些 VDPV 大多数是与 C 种非脊髓灰质炎肠道病毒(NPEV)发生基因重组的产物。目前,人们对有利于这种遗传宏观进化过程的因素知之甚少。自 2001 年以来,马达加斯加发生了几起因 VDPV 引起的脊髓灰质炎疫情,而大多数 VDPV 是在该岛南部分离出来的。本研究探讨了一些促进和解释马达加斯加重组 VDPV 出现的病毒因素。
2011 年 5 月至 8 月期间,我们从生活在马达加斯加南部和北部两个地区的健康儿童中采集粪便。在 RD、HEp-2c 和 L20B 细胞系中进行病毒分离,并使用广谱 5'-非翻译区 RT-PCR 检测肠道病毒。然后对 NPEV 进行 VP1 基因测序,用于病毒基因分型。
总体而言,我们共收集了 1309 份粪便,其中 351 份(26.8%)为 NPEV。测序结果显示,有 33 种病毒属于三个不同的种:肠道病毒 A(8.5%)、肠道病毒 B(EV-B,40.2%)和肠道病毒 C(EV-C,51.3%)。肠道病毒 C 种包括此前被描述为脊髓灰质炎疫苗株潜在重组伙伴的柯萨奇病毒 A13、A17 和 A20。有趣的是,南部地区的分离率较高(30.3%比 23.6%,p 值=0.009)。EV-C 在南部地区占优势(65.7%),而 EV-B 在北部地区占优势(54.9%)。南部地区 EV-C 相对丰度的解释因素仍不清楚。
无论其原因如何,马达加斯加南部 EV-C 的相对丰度可能促进了儿童感染 EV-C,包括 PV 疫苗株,并有利于感染儿童中 PV 与 NPEV 之间的重组事件,从而导致重组 VDPV 在马达加斯加该地区的反复出现。